Relevance tier by entity

Entity Tier Description
BL 2 Role of MYO18A mutations in BL requires confirmation

Mutation incidence in large patient cohorts (GAMBL reanalysis)

DLBCL

Entity Collection N mutated Incidence 95% CI
DLBCL GAMBL without Reddy 1,089 23 0.0211 [0.0126,0.0297]
DLBCL GAMBL with Reddy 2,088 50 0.0239 [0.0174,0.0305]
DLBCL BC 231 0 0.0004 [0,0.0031]
DLBCL Dana-Farber 303 6 0.0198 [0.0041,0.0355]
DLBCL NCI 470 16 0.0340 [0.0176,0.0504]
DLBCL Reddy 999 27 0.0270 [0.017,0.0371]
DLBCL DLBCL_ICGC 85 1 0.0118 [0,0.0347]

FL

pathology Collection N mutated Incidence CI
FL GAMBL without Crouch 642 13 0.0202 [0.0094,0.0311]
FL GAMBL with Crouch 1,189 14 0.0118 [0.0056,0.0179]
FL BC 379 9 0.0237 [0.0084,0.0391]
FL Kalmbach 164 3 0.0183 [0,0.0388]
FL Crouch 547 1 0.0018 [0,0.0054]
FL FL_ICGC 99 1 0.0101 [0,0.0298]

BL

Failed to render page: conflicting chdir during another chdir block

Mutation pattern and selective pressure estimates

Failed to render page: conflicting chdir during another chdir block

Failed to render page: conflicting chdir during another chdir block

Expression

Failed to render page: conflicting chdir during another chdir block

References

1.
Schmitz R, Young RM, Ceribelli M, Jhavar S, Xiao W, Zhang M, Wright G, Shaffer AL, Hodson DJ, Buras E, Liu X, Powell J, Yang Y, Xu W, Zhao H, Kohlhammer H, Rosenwald A, Kluin P, Müller-Hermelink HK, Ott G, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Ogwang MD, Reynolds SJ, Fisher RI, Braziel RM, Tubbs RR, Cook JR, Weisenburger DD, Chan WC, Pittaluga S, Wilson W, Waldmann TA, Rowe M, Mbulaiteye SM, Rickinson AB, Staudt LM. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature. 2012 Oct 4;490(7418):116–120. PMCID: PMC3609867